Page last updated: 2024-11-04

sb 202190 and Carcinoma, Oat Cell

sb 202190 has been researched along with Carcinoma, Oat Cell in 2 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Niiya, M1
Niiya, K1
Shibakura, M1
Asaumi, N1
Yoshida, C1
Shinagawa, K1
Teshima, T1
Ishimaru, F1
Ikeda, K1
Tanimoto, M1
Alam, M1
Wang, JH1
Coffey, JC1
Qadri, SS1
O'Donnell, A1
Aherne, T1
Redmond, HP1

Other Studies

2 other studies available for sb 202190 and Carcinoma, Oat Cell

ArticleYear
Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Oncology, 2004, Volume: 67, Issue:3-4

    Topics: Blotting, Northern; Blotting, Western; Butadienes; Carcinoma, Small Cell; Caspase 3; Caspases; Cell

2004
Characterization of the effects of cyclooxygenase-2 inhibition in the regulation of apoptosis in human small and non-small cell lung cancer cell lines.
    Annals of surgical oncology, 2007, Volume: 14, Issue:9

    Topics: Analysis of Variance; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small

2007